PMID- 30206943 OWN - NLM STAT- MEDLINE DCOM- 20200120 LR - 20200120 IS - 1097-4652 (Electronic) IS - 0021-9541 (Linking) VI - 234 IP - 3 DP - 2019 Mar TI - Cerebroprotective effects of hydrogen sulfide in homocysteine-induced neurovascular permeability: Involvement of oxidative stress, arginase, and matrix metalloproteinase-9. PG - 3007-3019 LID - 10.1002/jcp.27120 [doi] AB - An elevated level of homocysteine (Hcy) leads to hyperhomocysteinemia (HHcy), which results in vascular dysfunction and pathological conditions identical to stroke symptoms. Hcy increases oxidative stress and leads to increase in blood-brain barrier permeability and leakage. Hydrogen sulfide (H(2) S) production during the metabolism of Hcy has a cerebroprotective effect, although its effectiveness in Hcy-induced neurodegeneration and neurovascular permeability is less explored. Therefore, the current study was designed to perceive the neuroprotective effect of exogenous H (2) S against HHcy, a cause of neurodegeneration. To test this hypothesis, we used four groups of mice: control, Hcy, control + sodium hydrosulfide hydrate (NaHS), and Hcy + NaHS, and an HHcy mice model in Swiss albino mice by giving a dose of 1.8 g of dl-Hcy/L in drinking for 8-10 weeks. Mice that have 30 micromol/L Hcy were taken for the study, and a H (2) S supplementation of 20 mumol/L was given for 8 weeks to all groups of mice. HHcy results in the rise of the levels of superoxide and nitrite, although a concomitant decrease in the level of superoxide dismutase, catalase, glutathione peroxidase, reduced glutathione, and arginase in oxidative stress and a concomitant decrease in the endogenous level of H (2) S. Although H (2) S supplementation ameliorated, the effect of HHcy and the levels of H (2) S returned to the average level in HHcy animals supplemented with H (2) S. Interestingly, H (2) S supplementation ameliorated neurovascular remodeling and neurodegeneration. Thus, our study suggested that H (2) S could be a beneficial therapeutic candidate for the treatment of Hcy-associated neurodegeneration, such as stroke and neurovascular disorders. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Nath, Nibendu AU - Nath N AUID- ORCID: 0000-0003-4169-0581 AD - Department of LifeScience and Bioinformatics, Assam University, Silchar, India. FAU - Prasad, Himanshu Kishore AU - Prasad HK AUID- ORCID: 0000-0003-0215-1323 AD - Department of LifeScience and Bioinformatics, Assam University, Silchar, India. FAU - Kumar, Munish AU - Kumar M AD - Department of Biochemistry, University of Allahabad, Allahabad, India. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180912 PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (Neuroprotective Agents) RN - 0LVT1QZ0BA (Homocysteine) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) RN - YY9FVM7NSN (Hydrogen Sulfide) SB - IM MH - Animals MH - Blood-Brain Barrier/drug effects MH - Cerebrovascular Disorders/chemically induced/*drug therapy/metabolism/pathology MH - Disease Models, Animal MH - Homocysteine/toxicity MH - Humans MH - Hydrogen Sulfide/*pharmacology MH - Hyperhomocysteinemia/*drug therapy/genetics/metabolism/pathology MH - Matrix Metalloproteinase 9/genetics MH - Mice MH - Nerve Degeneration/chemically induced/*drug therapy/metabolism/pathology MH - Neuroprotective Agents/pharmacology MH - Oxidative Stress/drug effects MH - Permeability/drug effects MH - Stroke/drug therapy/metabolism/pathology OTO - NOTNLM OT - MMP-9 OT - arginase OT - blood-brain barrier OT - homocysteine OT - hydrogen sulfide OT - oxidative stress EDAT- 2018/09/13 06:00 MHDA- 2020/01/21 06:00 CRDT- 2018/09/13 06:00 PHST- 2018/05/16 00:00 [received] PHST- 2018/07/05 00:00 [accepted] PHST- 2018/09/13 06:00 [pubmed] PHST- 2020/01/21 06:00 [medline] PHST- 2018/09/13 06:00 [entrez] AID - 10.1002/jcp.27120 [doi] PST - ppublish SO - J Cell Physiol. 2019 Mar;234(3):3007-3019. doi: 10.1002/jcp.27120. Epub 2018 Sep 12.